Zeaxanthin Boosts Cancer Treatment, T-Cell Immunity
Why it matters: This discovery could lead to a simple, accessible dietary supplement improving advanced cancer treatments like immunotherapy.
- Zeaxanthin, a common eye-health nutrient, was found to enhance the activity of CD8+ T cells, crucial for identifying and destroying cancer cells.
- University of Chicago Medical Center researchers published findings in Cell Reports Medicine, detailing how zeaxanthin stabilizes T-cell receptor formation, leading to stronger anti-tumor responses.
- Mouse studies showed that zeaxanthin slowed tumor growth, and its effect was even more pronounced when combined with immune checkpoint inhibitors, a type of immunotherapy.
- Laboratory experiments demonstrated zeaxanthin's ability to enhance human T cells' capacity to destroy melanoma, multiple myeloma, and glioblastoma cells.
A common eye-health nutrient, zeaxanthin, found in everyday vegetables, has been discovered to significantly boost the body's anti-cancer immunity by strengthening T cells and enhancing the effectiveness of immunotherapy treatments. Researchers at the University of Chicago Medical Center found that this safe and accessible compound could improve both natural and engineered T-cell responses against various cancers, with human trials as the next crucial step.
